Insomnia and risk of cardiovascular disease: a meta-analysis
By F. Sofi, F. Cesari, A. Casini, C. Macchi, Rosanna Abbate, Gian Franco Gensini. European Journal of Preventive Cardiology, 2014
654 citations recorded by the source corpus.
Subfields: Cognitive Neuroscience, Endocrine and Autonomic Systems, Experimental and Cognitive Psychology
View Paper: https://www.semanticscholar.org/paper/8bae441f477a5ae2d077dc8da6e9c0f22cf82f32
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cognitive Neuroscience
In Endocrine and Autonomic Systems
In Experimental and Cognitive Psychology
Citations in the corpus
- The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023 (2023, background): “Insomnia is highly prevalant also in medical disorders including diabetes (LeBlanc et al., 2018) and cardiovascular disease/ hypertension (Li, Gan, et al., 2021; Li, Li, et al., 2021; Sofi et al., 2014).”
- European guideline for the diagnosis and treatment of insomnia (2017, positive): “Several meta-analyses show that insomnia is a significant risk factor for cardiovascular diseases (Li et al., 2014; Meng et al., 2013; Sofi et al., 2014).”
- Effects of aromatherapy on sleep quality in patients: Protocol for an umbrella review (2025, positive): “Poor sleep quality hinders recovery and survival, impairs cognitive function, prolongs treatment duration, and increases the risk of comorbidities such as diabetes and cardiovascular diseases [8,9].”